Literature DB >> 10646785

Histology of the neobladder mucosa after sigmoidocolocystoplasty.

T Miyano1, A Yamataka, K Iwashita, A Morioka, G J Lane, H Kobayashi, T Okazaki.   

Abstract

PURPOSE: The aim of this study was to examine the histopathology of neobladder mucosa biopsy specimens obtained routinely as part of postsigmoidocolocystoplasty (SCP) follow-up.
METHODS: One hundred cases of SCP (mean age at surgery, 10.6 years) performed by the authors were examined for the presence of dysplasia or malignant changes in the mucosa of the neobladder using H&E and proliferating cell nuclear antigen (PCNA) staining.
RESULTS: No dysplastic or malignant changes were identified in any case. Metaplasia was found in 5 cases and hyperplasia in 2. There were no major differences found on H&amp;E and PCNA staining of specimens obtained after different periods of follow-up post-SCP; follow-up was short term (up to 5 years) in 44 cases, medium term (from 5 to 10 years) in 48 cases, and long term (over 10 years) in 8 cases. PCNA staining was significantly more intense in subjects who stopped regular bladder irrigations (BI) post-SCP and in subjects in whom bladder stones developed (P < .05; Welch's t test), compared with subjects who continued BI and subjects in whom bladder stones did not develop.
CONCLUSIONS: After SCP, patients are advised to continue BI. Regular biopsies should be part of routine follow-up, especially in subjects with bladder stones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646785     DOI: 10.1016/s0022-3468(00)80024-x

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Sigmoidocolocystoplasty for augmentation of iatrogenic small capacity bladder caused by direct injury to the bladder during inguinal hernia repair: long-term follow-up.

Authors:  Go Miyano; Atsuyuki Yamataka; Yasuhiro Okada; Akihiro Shimotakahara; Kazunari Kaneko; Geoffrey J Lane; Yuichiro Yamashiro; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2004-02-01       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.